Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions: Hormone-Resistant Prostate Cancer; Recurrent Prostate CarcinomaInterventions: Drug: Bicalutamide; Drug: Pazopanib Hydrochloride; Other: Pharmacological Study; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified July 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hormonal Therapy | Hormones | Prostate Cancer | Research | Study